WallStreetZen

NYSE: UNH
Unitedhealth Group Inc Stock Ownership

Insider buying vs selling

Have Unitedhealth Group Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Thomas E. RoosChief Accounting Officer2021-04-275,301$394.66
$2.09MSell
Thomas E. RoosChief Accounting Officer2021-04-2618,184$399.81
$7.27MSell
Thomas E. RoosChief Accounting Officer2021-04-2626,137$160.31
$4.19MBuy
Richard T. BurkeDirector2021-04-202,500$391.25
$978.13kSell
Richard T. BurkeDirector2021-04-2010,000$395.43
$3.95MSell
Richard T. BurkeDirector2021-04-192,500$391.25
$978.13kSell
Patricia L. LewisEVP and Chief HR Officer2021-04-163,000$389.99
$1.17MSell
Richard T. BurkeDirector2021-03-166,000$354.90
$2.13MSell
Richard T. BurkeDirector2021-03-154,000$353.33
$1.41MSell
Thomas E. RoosChief Accounting Officer2021-03-01423$334.36
$141.43kSell

1 of 9

UNH insiders have sold more UNH shares than they have bought in the last year
Ownership

UNH Shareholders

What type of owners hold Unitedhealth Group Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc8.37%79,092,547$33.03BInstitution
Blackrock Inc7.57%71,592,885$29.90BInstitution
Fmr LLC5.56%52,565,986$21.95BInstitution
State Street Corp4.68%44,227,842$18.47BInstitution
Price T Rowe Associates Inc4.02%38,003,233$15.87BInstitution
Capital World Investors3.72%35,185,176$14.70BInstitution
Wellington Management Group Llp3.57%33,778,311$14.11BInstitution
Capital Research Global Investors2.32%21,957,767$9.17BInstitution
Capital International Investors1.89%17,859,164$7.46BInstitution
Geode Capital Management LLC1.50%14,157,080$5.91BInstitution

1 of 3

Unitedhealth Group Stock Ownership FAQ

Who owns Unitedhealth Group?

Unitedhealth Group (NYSE: UNH) is owned by 87.47% institutional shareholders, 2.01% Unitedhealth Group insiders, and 10.52% retail investors. Edson De Godoy Bueno is the largest individual Unitedhealth Group shareholder, owning 8.79M shares representing 0.93% of the company. Edson De Godoy Bueno's Unitedhealth Group shares are currently valued at $3.65B.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.